<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36071155</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5403</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>Long Covid: where we stand and challenges ahead.</ArticleTitle><Pagination><StartPage>1891</StartPage><EndPage>1900</EndPage><MedlinePgn>1891-1900</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41418-022-01052-6</ELocationID><Abstract><AbstractText>Post-acute sequelae of SARS-CoV-2 (PASC), also known as Post-Covid Syndrome, and colloquially as Long Covid, has been defined as a constellation of signs and symptoms which persist for weeks or months after the initial SARS-CoV-2 infection. PASC affects a wide range of diverse organs and systems, with manifestations involving lungs, brain, the cardiovascular system and other organs such as kidney and the neuromuscular system. The pathogenesis of PASC is complex and multifactorial. Evidence suggests that seeding and persistence of SARS-CoV-2 in different organs, reactivation, and response to unrelated viruses such as EBV, autoimmunity, and uncontrolled inflammation are major drivers of PASC. The relative importance of pathogenetic pathways may differ in different tissue and organ contexts. Evidence suggests that vaccination, in addition to protecting against disease, reduces PASC after breakthrough infection although its actual impact remains to be defined. PASC represents a formidable challenge for health care systems and dissecting pathogenetic mechanisms may pave the way to targeted preventive and therapeutic approaches.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5578-236X</Identifier><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy. alberto.mantovani@humanitasresearch.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy. alberto.mantovani@humanitasresearch.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William Harvey Research Institute, Queen Mary University, London, EC1M 6BQ, UK. alberto.mantovani@humanitasresearch.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrone</LastName><ForeName>Maria Concetta</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Scientific Institute Stella Maris (IRCSS), Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrono</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Pharmacology, Catholic University School of Medicine, and Fondazione Policlinico Universitario "A. Gemelli" Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>M Gabriella</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome Tor Vergata, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Pharmacology, CNR, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiaffino</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Venetian Institute of Molecular Medicine, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remuzzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bussolati</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2175-5069</Identifier><AffiliationInfo><Affiliation>Accademia Nazionale dei Lincei, Rome, Italy. gianni.bussolati@unito.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Turin, Turin, Italy. gianni.bussolati@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Covid-19 Commission of the Accademia Nazionale dei Lincei</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>AM is inventor of patents related to PTX3 and receives royalties for the sale of reagents related to innate immunity.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cappuccinelli</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Garrett</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacci</LastName><ForeName>Massimo Livi</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melino</LastName><ForeName>Gennaro</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parisi</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rappuoli</LastName><ForeName>Rino</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rezza</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vineis</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36071155</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pii">10.1038/s41418-022-01052-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, et al. Post-Covid-19 syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11:524. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-Covid-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long Covid: a living systematic review. BMJ Glob Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S, et al. Depression pandemic and cardiovascular risk in the Covid-19 era and long Covid syndrome: gender makes a difference. Trends Cardiovasc Med. 2022;32:12&#x2013;17. doi: 10.1016/j.tcm.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci PM, Nobili A, Tettamanti M, D&#x2019;Avanzo B, Galbussera AA, Remuzzi G, et al. Impact of the post-Covid-19 condition on health care after the first disease wave in Lombardy. J Intern Med. 2022;292:450&#x2013;62. doi: 10.1111/joim.13493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13493</ArticleId><ArticleId IdType="pmc">PMC9115275</ArticleId><ArticleId IdType="pubmed">35373863</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, O&#x2019;Mahoney L, Ayoubkhani D, Banerjee A, Brightling C, Calvert M, et al. Understanding and tracking the impact of long Covid in the United Kingdom. Nat Med. 2022;28:11&#x2013;15. doi: 10.1038/s41591-021-01591-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01591-4</ArticleId><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long Covid: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;21. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of Covid-19: a systematic review and meta-analysis of one-year follow-up studies on post-Covid symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich H-G, Brockmann SO, G&#xf6;pel S, Kindle G, et al. Prevalence, determinants, and impact on general health and working capacity of post-acute sequelae of Covid-19 six to 12 months after infection: a population-based retrospective cohort study from southern Germany. medRxiv:2022031422272316 [Preprint]. 2022. Available from: 10.1101/2022.03.14.22272316.</Citation></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute Covid-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:657&#x2013;66. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodriguez Y, Roa G, Lozano M, et al. Post-Covid syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20:102947. doi: 10.1016/j.autrev.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, et al. Persistent neuropsychiatric symptoms after Covid-19: a systematic review and meta-analysis. Brain Commun. 2022;4:fcab297. doi: 10.1093/braincomms/fcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post Covid-19 condition or long covid: a meta-analysis and systematic review. J Infect Dis. 2022:jiac136. 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long Covid: a rapid review and meta-analysis. J Glob Health. 2022;12:05014. doi: 10.7189/jogh.12.05014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-Covid syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow-ups on persistent symptoms and pulmonary function among post-acute Covid-19 patients: a systematic review and meta-analysis. Front Med. 2021;8:702635. doi: 10.3389/fmed.2021.702635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of Covid-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute Covid-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94:253&#x2013;62. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Jody AA, Nunsio PN, Buana RB. Persistent neurological manifestations in long Covid-19 syndrome: a systematic review and meta-analysis. J Infect Public Health. 2022;15:856&#x2013;69. doi: 10.1016/j.jiph.2022.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-Covid-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long Covid. J Am Soc Nephrology: JASN. 2021;32:2851&#x2013;62. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jimenez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (Covid-19): a systematic review and meta-analysis. Chron Respir Dis. 2021;18:14799731211002240. doi: 10.1177/14799731211002240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. Post-acute Covid-19 syndrome. Eur Respir Rev. 2022;31:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long Covid syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Aalokken TM, Bronstad E, Aarli B, Ikdahl E, Lund KMA, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for Covid-19. Eur Resp J. 2021;57:2003448. doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>McGroder CF, Zhang D, Choudhury MA, Salvatore MM, D&#x2019;Souza BM, Hoffman EA, et al. Pulmonary fibrosis 4 months after Covid-19 is associated with severity of illness and blood leucocyte telomere length. Thorax. 2021;76:1242&#x2013;5. doi: 10.1136/thoraxjnl-2021-217031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217031</ArticleId><ArticleId IdType="pmc">PMC8103561</ArticleId><ArticleId IdType="pubmed">33927016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following Covid-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747&#x2013;54. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Schuepbach R, Probst-Mueller E, Frontzek K, Brugger SD, et al. Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 Covid-19 autopsies. Front Med. 2022;9:778489. doi: 10.3389/fmed.2022.778489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.778489</ArticleId><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="pubmed">35223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun HJ, Coutavas E, Pine A, Lee AI, Yu V, Shallow M, et al. Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). medRxiv 2021. 10.1101/2021.01.31.21250870.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Li DL, Davogustto G, Soslow JH, Wassenaar JW, Parikh AP, Chew JD, et al. Characteristics of Covid-19 myocarditis with and without multisystem inflammatory syndrome. Am J Cardiol. 2022;168:135&#x2013;41. doi: 10.1016/j.amjcard.2021.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.12.031</ArticleId><ArticleId IdType="pmc">PMC8767902</ArticleId><ArticleId IdType="pubmed">35058054</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehmer TK, Kompaniyets L, Lavery AM, Hsu J, Ko JY, Yusuf H, et al. Association between Covid-19 and myocarditis using hospital-based administrative data - United States, March 2020&#x2013;January 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1228&#x2013;32. doi: 10.15585/mmwr.mm7035e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7035e5</ArticleId><ArticleId IdType="pmc">PMC8422872</ArticleId><ArticleId IdType="pubmed">34473684</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Siddiqi H, Zhou G, Vieira J, Kim A, Rutherford H, et al. Relationship between myocardial injury during index hospitalization for SARS-CoV-2 infection and longer-term outcomes. J Am Heart Assoc. 2022;11:e022010. doi: 10.1161/JAHA.121.022010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.022010</ArticleId><ArticleId IdType="pmc">PMC9075193</ArticleId><ArticleId IdType="pubmed">34970914</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarpak L, Pruc M, Filipiak KJ, Popieluch J, Bielski A, Jaguszewski MJ, et al. Myocarditis: a complication of Covid-19 and long-Covid-19 syndrome as a serious threat in modern cardiology. Cardiol J. 2022;29:178&#x2013;9. doi: 10.5603/CJ.a2021.0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0155</ArticleId><ArticleId IdType="pmc">PMC8890406</ArticleId><ArticleId IdType="pubmed">34811716</ArticleId></ArticleIdList></Reference><Reference><Citation>Crea F. European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long Covid. Eur Heart J. 2022;43:1017&#x2013;21. doi: 10.1093/eurheartj/ehac087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac087</ArticleId><ArticleId IdType="pubmed">35284919</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Salazar B, Holwerda M, Studle C, Piragyte I, Mercader N, Engelhardt B, et al. Covid-19 and the vasculature: current aspects and long-term consequences. Front Cell Dev Biol. 2022;10:824851. doi: 10.3389/fcell.2022.824851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long Covid: post-acute sequelae of Covid-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;72. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of Covid-19. Nat Med. 2022;28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranyo J, Bazan V, Llados G, Dominguez MJ, Bisbal F, Massanella M, et al. Inappropriate sinus tachycardia in post-Covid-19 syndrome. Sci Rep. 2022;12:298. doi: 10.1038/s41598-021-03831-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03831-6</ArticleId><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C, Tudoran M, Cut TG, Lazureanu VE, Oancea C, Marinescu AR, et al. Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from Covid-19. J Pers Med. 2022;12:46&#x2013;54. 10.3390/jpm12010046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778114</ArticleId><ArticleId IdType="pubmed">35055360</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O, Varionchik N, Zaidenov V, Savina P, Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis Covid-19. Eur J Immunol. 2021;51:893&#x2013;902. doi: 10.1002/eji.202048930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048930</ArticleId><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle. 2022;13:11&#x2013;22. doi: 10.1002/jcsm.12896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Bose S, Banner-Goodspeed V, Beesley SJ, Dinglas VD, Hopkins RO, et al. Approaches to addressing post-intensive care syndrome among intensive care unit survivors. A narrative review. Ann Am Thorac Soc. 2019;16:947&#x2013;56. doi: 10.1513/AnnalsATS.201812-913FR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201812-913FR</ArticleId><ArticleId IdType="pubmed">31162935</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel HH, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78:948&#x2013;60. doi: 10.1001/jamaneurol.2021.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65:440&#x2013;3. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuby J, Roth R, Strecker N, Teubner J, Rudiger A. Post-Covid-19 bifacial weakness and paraesthesia: a case report. Swiss Med Wkly. 2021;151:w30066.</Citation><ArticleIdList><ArticleId IdType="pubmed">34569221</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long Covid in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;13. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. One-year trajectory of cognitive changes in older survivors of Covid-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;17. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute Covid-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long Covid in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Najt P, Richards HL, Fortune DG. Brain imaging in patients with Covid-19: a systematic review. Brain Behav Immun Health. 2021;16:100290. doi: 10.1016/j.bbih.2021.100290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100290</ArticleId><ArticleId IdType="pmc">PMC8249107</ArticleId><ArticleId IdType="pubmed">34230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic Covid-19 patients. J Nucl Med. 2021;62:910&#x2013;5. doi: 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of Covid-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;27. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long Covid syndrome: a cross-sectional study from 50,402 Covid-19 patients. Infection 2022. 10.1007/s15010-022-01784-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="pubmed">35355237</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer PE, Kirwan JP, Rosen CJ. Post-acute sequelae of Covid-19: a metabolic perspective. Elife. 2022;11:e78200. doi: 10.7554/eLife.78200.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D&#x2019;Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3:774&#x2013;85. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneni F, Patrono C. Increased risk of incident diabetes in patients with long Covid. Eur Heart J. 2022;43:2094&#x2013;5. doi: 10.1093/eurheartj/ehac196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac196</ArticleId><ArticleId IdType="pubmed">35417544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute Covid-19 syndrome. Nat Med. 2021;27:601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, et al. Immune response in Covid-19: what is next? Cell Death Diff. 2022;29:1107&#x2013;22. doi: 10.1038/s41418-022-01015-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01015-x</ArticleId><ArticleId IdType="pmc">PMC9110941</ArticleId><ArticleId IdType="pubmed">35581387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long Covid/PASC: origins and therapeutic implications. Biochem J. 2022;479:537&#x2013;59. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post-acute sequelae of Covid-19. Front Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T, et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e2011335. doi: 10.1001/jamanetworkopen.2020.11335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.11335</ArticleId><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JS, Caricchio R, Casanova JL, Combes AJ, Diamond B, Fox SE, et al. The intersection of Covid-19 and autoimmunity. J Clin Invest. 2021;131:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Are vaccines safe in patients with Long Covid? A prospective observational study. medRxiv:2021031121253225 [Preprint]. 2021. Available from: 10.1101/2021.03.11.21253225.</Citation></Reference><Reference><Citation>Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. Covid-19 infection: the perspectives on immune responses. Cell Death Diff. 2020;27:1451&#x2013;4. doi: 10.1038/s41418-020-0530-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0530-3</ArticleId><ArticleId IdType="pmc">PMC7091918</ArticleId><ArticleId IdType="pubmed">32205856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zheng Y, Niu Z, Zhang B, Wang C, Yao X, et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Diff. 2021;28:2765&#x2013;77. doi: 10.1038/s41418-021-00782-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00782-3</ArticleId><ArticleId IdType="pmc">PMC8056997</ArticleId><ArticleId IdType="pubmed">33879858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Diff. 2021;28:2019&#x2013;21. doi: 10.1038/s41418-021-00795-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00795-y</ArticleId><ArticleId IdType="pmc">PMC8114657</ArticleId><ArticleId IdType="pubmed">33981020</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following Covid-19. Nat Rev Rheumatol. 2020;16:413&#x2013;4. doi: 10.1038/s41584-020-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JL, Abel L. Mechanisms of viral inflammation and disease in humans. Science. 2021;374:1080&#x2013;6. doi: 10.1126/science.abj7965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj7965</ArticleId><ArticleId IdType="pmc">PMC8697421</ArticleId><ArticleId IdType="pubmed">34822298</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts DR, Getts MT, King NJC, Miller SD. Infectious triggfers of T cell autoimmunity. In: Rose NR, editor. The autoimmune diseases, fifth edition. Elsevier; 2014;p. 263&#x2013;74.</Citation></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. Immunoglobulin signature predicts risk of post-acute Covid-19 syndrome. Nat Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in Covid-19. Nat Immunol. 2021;22:19&#x2013;24. doi: 10.1038/s41590-020-00832-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00832-x</ArticleId><ArticleId IdType="pubmed">33208929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Forni G, Mantovani A. Ten things we learned about Covid-19. Intensive Care Med. 2020;46:1590&#x2013;3. doi: 10.1007/s00134-020-06140-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06140-0</ArticleId><ArticleId IdType="pmc">PMC7273118</ArticleId><ArticleId IdType="pubmed">32504103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl J Med. 2020;383:120&#x2013;8. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in Covid-19. Lancet. 2020;395:1417&#x2013;8. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in Covid-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Luscher T. Covid-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038&#x2013;44. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaldi A, Gritti G, Mico MC, Frigeni M, Borleri G, Salvi A, et al. Endothelial injury and thrombotic microangiopathy in Covid-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020;225:152001. doi: 10.1016/j.imbio.2020.152001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2020.152001</ArticleId><ArticleId IdType="pmc">PMC7415163</ArticleId><ArticleId IdType="pubmed">32943233</ArticleId></ArticleIdList></Reference><Reference><Citation>Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275&#x2013;86. doi: 10.1038/s41590-021-01114-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01114-w</ArticleId><ArticleId IdType="pubmed">35102342</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, Islam S, Bindra GK, Engwirda J, Ratcliffe J, Zhou J, et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in Covid-19. Nat Commun. 2022;13:3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. Mild respiratory Covid can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;68.e2416. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul Covid. Nat Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D, Stein S, Ramelli S, Grazioli A, Chung JY, Singh M, et al. SARS-CoV-2 infection and persistence throughout the human body and brain. Res Sq. 2021. 10.21203/rs.3.rs-1139035/v1.</Citation></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;44. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. Covid-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2022;14:1&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol. 2006;4:121&#x2013;32. doi: 10.1038/nrmicro1343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1343</ArticleId><ArticleId IdType="pmc">PMC7096820</ArticleId><ArticleId IdType="pubmed">16415928</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, et al. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proc Natl Acad Sci USA. 2020;117:15902&#x2013;10. doi: 10.1073/pnas.2003432117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003432117</ArticleId><ArticleId IdType="pmc">PMC7355048</ArticleId><ArticleId IdType="pubmed">32571951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipar A, Meli ML, Baptiste KE, Bowker LJ, Lutz H. Sites of feline coronavirus persistence in healthy cats. J Gen Virol. 2010;91:1698&#x2013;707. doi: 10.1099/vir.0.020214-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.020214-0</ArticleId><ArticleId IdType="pubmed">20237226</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N, Cote G, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol. 1999;73:3338&#x2013;50. doi: 10.1128/JVI.73.4.3338-3350.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.3338-3350.1999</ArticleId><ArticleId IdType="pmc">PMC104098</ArticleId><ArticleId IdType="pubmed">10074188</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N, Ekande S, Cote G, Lachance C, Chagnon F, Tardieu M, et al. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol. 1999;73:3326&#x2013;37. doi: 10.1128/JVI.73.4.3326-3337.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.3326-3337.1999</ArticleId><ArticleId IdType="pmc">PMC104097</ArticleId><ArticleId IdType="pubmed">10074187</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, et al. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol. 2004;74:1&#x2013;7. doi: 10.1002/jmv.20138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20138</ArticleId><ArticleId IdType="pmc">PMC7166317</ArticleId><ArticleId IdType="pubmed">15258961</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Subudhi S, Rapin N, Lew J, Jain R, Falzarano D, et al. Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus. Sci Rep. 2020;10:7257. doi: 10.1038/s41598-020-64264-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64264-1</ArticleId><ArticleId IdType="pmc">PMC7190632</ArticleId><ArticleId IdType="pubmed">32350357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yoon GY, Myoung J, Kim SJ, Ahn DG. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg Microbes Infect. 2020;9:2169&#x2013;79. doi: 10.1080/22221751.2020.1827985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1827985</ArticleId><ArticleId IdType="pmc">PMC7580600</ArticleId><ArticleId IdType="pubmed">32969768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamage AM, Tan KS, Chan WOY, Lew ZZR, Liu J, Tan CW, et al. Human nasal epithelial cells sustain persistent SARS-CoV-2 infection in vitro, despite eliciting a prolonged antiviral response. mBio. 2022;13. 10.1128/mbio.03436-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764519</ArticleId><ArticleId IdType="pubmed">35038898</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020;369:1249&#x2013;55. doi: 10.1126/science.abc8665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov A, Girault V, Grass V, Karayel O, Bergant V, Urban C, et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021;594:246&#x2013;52. doi: 10.1038/s41586-021-03493-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03493-4</ArticleId><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran E, Cook T, Goodman AL, Gupta RK, Jolles S, Menon DK, et al. Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials. Lancet Infect Dis. 2021;21:1345&#x2013;7. doi: 10.1016/S1473-3099(21)00464-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00464-3</ArticleId><ArticleId IdType="pmc">PMC8367192</ArticleId><ArticleId IdType="pubmed">34411531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Fan J, Huang J, Guo E, Fu Y, Liu S, et al. Clinical and molecular characteristics of Covid-19 patients with persistent SARS-CoV-2 infection. Nat Commun. 2021;12:3501. doi: 10.1038/s41467-021-23621-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23621-y</ArticleId><ArticleId IdType="pmc">PMC8190301</ArticleId><ArticleId IdType="pubmed">34108465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci USA. 2021;118:e2105968118. doi: 10.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornich BF, Grosskopf AK, Schlagowski S, Tenbusch M, Kleine-Weber H, Neipel F, et al. SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in their requirements for receptor expression and proteolytic activation. J Virol. 2021;95:e00002&#x2013;21. doi: 10.1128/JVI.00002-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00002-21</ArticleId><ArticleId IdType="pmc">PMC8104116</ArticleId><ArticleId IdType="pubmed">33608407</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccio A, Santopolo S, Rossi A, Piacentini S, Rossignol JF, Santoro MG. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Cell Mol Life Sci. 2022;79:227. doi: 10.1007/s00018-022-04246-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04246-w</ArticleId><ArticleId IdType="pmc">PMC8989121</ArticleId><ArticleId IdType="pubmed">35391601</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. Measles virus persistence and its consequences. Curr Opin Virol. 2020;41:46&#x2013;51. doi: 10.1016/j.coviro.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.03.003</ArticleId><ArticleId IdType="pmc">PMC7492426</ArticleId><ArticleId IdType="pubmed">32387998</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton AA, Schwartz O. They might be giants: does syncytium formation sink or spread HIV infection? PLoS Pathog. 2017;13:e1006099. doi: 10.1371/journal.ppat.1006099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006099</ArticleId><ArticleId IdType="pmc">PMC5289631</ArticleId><ArticleId IdType="pubmed">28152024</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol. 2008;6:815&#x2013;26. doi: 10.1038/nrmicro1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1972</ArticleId><ArticleId IdType="pubmed">18923409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, et al. SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci USA 2022;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740724</ArticleId><ArticleId IdType="pubmed">34937699</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain T, Sharp SJ, Spiers A, Price H, Williams C, Fraser C, et al. Population level physical activity before and during the first national Covid-19 lockdown: a nationally representative repeat cross-sectional study of 5 years of active lives data in England. Lancet Reg Health Eur. 2022;12:100265. doi: 10.1016/j.lanepe.2021.100265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100265</ArticleId><ArticleId IdType="pmc">PMC8629728</ArticleId><ArticleId IdType="pubmed">34870255</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the Covid Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med. 2021;27:790&#x2013;2. doi: 10.1038/s41591-021-01316-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01316-7</ArticleId><ArticleId IdType="pubmed">33782619</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein M, Ashkenazi-Hoffnung L, Greenberg D, Dalal I, Livni G, Chapnick G, et al. The burden of Covid-19 in children and its prevention by vaccination: a joint statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines 2022;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781684</ArticleId><ArticleId IdType="pubmed">35062742</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long Covid after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association between vaccination with BNT162b2 vaccine and Long Covid after infections not requiring hospitalization in healthcare workers. JAMA 2022:328:676&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Beiruti Wiegler K, Abu, et al. Association between vaccination status and reported incidence of post-acute Covid-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv:2022010522268800 [Preprint]. 2022. Available from: 10.1101/2022.01.05.22268800.</Citation></Reference><Reference><Citation>Seessle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (Covid-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;8. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Rosso A, Cecchini P, Torrigiani A, Lo Forte A, Carrai P, et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post Covid-19 respiratory syndrome. Infection. 2022;50:513&#x2013;7. doi: 10.1007/s15010-022-01755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01755-5</ArticleId><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="pubmed">35061232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortunato F, Martinelli D, Iannelli G, Milazzo M, Farina U, Di Matteo G, et al. Self-reported olfactory and gustatory dysfunctions in Covid-19 patients: a 1-year follow-up study in Foggia district, Italy. BMC Infect Dis. 2022;22:77. doi: 10.1186/s12879-022-07052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07052-8</ArticleId><ArticleId IdType="pmc">PMC8783175</ArticleId><ArticleId IdType="pubmed">35065619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post Covid-19 disease symptoms over time in the ComPaRe long Covid prospective e-cohort. Nat Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodriguez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with Covid-19: a longitudinal cohort study. Lancet Respir Med. 2022.S2213-2600(22)00126-6. 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long Covid associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>